急性缺血性卒中患者肌钙蛋白阳性与超声心动图表现及死亡率的关联
在1999例急性缺血性卒中患者中,20.7%存在肌钙蛋白升高,10.1%有超声心动图异常发现;肌钙蛋白升高与超声心动图发现独立相关(OR 2.9),排除并发心梗后仍与1年(OR 3.45)和3年(OR 2.91)死亡率增加相关。
要点
- 急性缺血性卒中患者肌钙蛋白升高发生率为20.7%,超声心动图异常发现率为10.1%。
- 肌钙蛋白升高与超声心动图结构异常独立相关(OR 2.9, 95%CI 2-4.2)。
- 排除并发心梗后,肌钙蛋白升高仍与1年和3年死亡率增加相关。
核心结论
- 急性缺血性卒中无并发心梗时,肌钙蛋白升高与结构性心脏病及长期死亡率相关。
主要发现
- 1999例中1706例(85.3%)检测肌钙蛋白,1590例(79.5%)行超声心动图。
- 肌钙蛋白升高者353/1706(20.7%),超声心动图异常发现者160/1590(10.1%)。
- 1377例同时完成两项检查者中,肌钙蛋白升高与超声心动图发现独立相关(OR 2.9, 95%CI 2-4.2)。
- 排除并发心梗(3.5%)后,肌钙蛋白升高与1年死亡率(35%)相关(OR 3.45, 95%CI 2.1-5.6)。
- 肌钙蛋白升高与3年死亡率(60%)相关(OR 2.91, 95%CI 2.06-4.11)。
关键数值与推荐
- 肌钙蛋白升高定义为超过标准99百分位。
- 多因素logistic回归控制卒中严重程度、心脏病史及其他卒中危险因素。
临床怎么用
- 急性缺血性卒中患者应关注肌钙蛋白升高,提示需进一步心脏评估以识别结构性心脏病。
局限性
- 回顾性研究设计,需前瞻性研究验证进一步心脏评估能否改善长期死亡率。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND PURPOSE: Acute ischemic stroke (AIS) patients may have raised serum cardiac troponin levels on admission, although it is unclear what prognostic implications this has, and whether elevated levels are associated with cardiac causes of stroke or structural cardiac disease as seen on echocardiogram. We investigated the positivity of cardiac troponin and echocardiogram testing within a large biracial AIS population and any association with poststroke mortality. METHODS: Within a catchment area of 1.3 million, we screened emergency department admissions from 2010 using International Classification of Diseases, Ninth Edition, discharge codes 430 to 436 and ascertained all physician-confirmed AIS cases by retrospective chart review. Hypertroponinemia was defined as elevation in cardiac troponin above the standard 99th percentile. Multiple logistic regression was performed, controlling for stroke severity, history of cardiac disease, and all other stroke risk factors. RESULTS: Of 1999 AIS cases, 1706 (85.3%) had a cardiac troponin drawn and 1590 (79.5%) had echocardiograms. Hypertroponinemia occurred in 353 of 1706 (20.7%) and 160 of 1590 (10.1%) had echocardiogram findings of interest. Among 1377 who had both tests performed, hypertroponinemia was independently associated with echocardiogram findings (odds ratio, 2.9; 95% confidence interval, 2-4.2). When concurrent myocardial infarctions (3.5%) were excluded, hypertroponinemia was also associated with increased mortality at 1 year (35%; odds ratio, 3.45; 95% confidence interval, 2.1-5.6) and 3 years (60%; odds ratio, 2.91; 95% confidence interval, 2.06-4.11). CONCLUSIONS: Hypertroponinemia in the context of AIS without concurrent myocardial infarction was associated with structural cardiac disease and long-term mortality. Prospective studies are needed to determine whether further cardiac evaluation might improve the long-term mortality rates seen in this group.
引用
- Wrigley P, Khoury J, Eckerle B, et al. Prevalence of Positive Troponin and Echocardiogram Findings and Association With Mortality in Acute Ischemic Stroke. Stroke. 2017. PMID: 28381647. doi:10.1161/STROKEAHA.116.014561
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。